Public health and medical care for the world's factory: China's Pearl River Delta Region

Guilhem Fabre, Victor G. Rodwin

Research output: Contribution to journalComment/debate

Abstract

While the growth of urbanization, worldwide, has improved the lives of migrants from the hinterland, it also raises health risks related to population density, concentrated poverty and the transmission of infectious disease. Will megacity regions evolve into socially infected breeding grounds for the rapid transmission of disease, or can they become critical spatial entities for the protection and promotion of population health? We address this question for the Pearl River Delta Region (PRD) based on recent data from Chinese sources, and on the experience of how New York, Greater London, Tokyo and Paris have grappled with the challenges of protecting population health and providing their populations with access to health care services. In some respects, there are some important lessons from comparative experience for PRD, notably the importance of covering the entire population for health care services and targeting special programs for those at highest risk for disease. In other respects, PRD's growth rate and sheer scale make it a unique megacity region that already faces new challenges and will require new solutions.

Original languageEnglish (US)
Article number110
JournalBMC Medicine
Volume9
DOIs
StatePublished - Oct 4 2011

Fingerprint

Rivers
China
Public Health
Delivery of Health Care
Population
Health Services
Urbanization
Health Services Accessibility
Infectious Disease Transmission
Tokyo
Information Storage and Retrieval
Health
Paris
Poverty
Growth
Population Density
Health Promotion
Breeding

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Public health and medical care for the world's factory : China's Pearl River Delta Region. / Fabre, Guilhem; Rodwin, Victor G.

In: BMC Medicine, Vol. 9, 110, 04.10.2011.

Research output: Contribution to journalComment/debate

@article{2028a8fe82864f07a3c72a39cf0c621f,
title = "Public health and medical care for the world's factory: China's Pearl River Delta Region",
abstract = "While the growth of urbanization, worldwide, has improved the lives of migrants from the hinterland, it also raises health risks related to population density, concentrated poverty and the transmission of infectious disease. Will megacity regions evolve into socially infected breeding grounds for the rapid transmission of disease, or can they become critical spatial entities for the protection and promotion of population health? We address this question for the Pearl River Delta Region (PRD) based on recent data from Chinese sources, and on the experience of how New York, Greater London, Tokyo and Paris have grappled with the challenges of protecting population health and providing their populations with access to health care services. In some respects, there are some important lessons from comparative experience for PRD, notably the importance of covering the entire population for health care services and targeting special programs for those at highest risk for disease. In other respects, PRD's growth rate and sheer scale make it a unique megacity region that already faces new challenges and will require new solutions.",
author = "Guilhem Fabre and Rodwin, {Victor G.}",
year = "2011",
month = "10",
day = "4",
doi = "10.1186/1741-7015-9-110",
language = "English (US)",
volume = "9",
journal = "BMC Medicine",
issn = "1741-7015",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Public health and medical care for the world's factory

T2 - China's Pearl River Delta Region

AU - Fabre, Guilhem

AU - Rodwin, Victor G.

PY - 2011/10/4

Y1 - 2011/10/4

N2 - While the growth of urbanization, worldwide, has improved the lives of migrants from the hinterland, it also raises health risks related to population density, concentrated poverty and the transmission of infectious disease. Will megacity regions evolve into socially infected breeding grounds for the rapid transmission of disease, or can they become critical spatial entities for the protection and promotion of population health? We address this question for the Pearl River Delta Region (PRD) based on recent data from Chinese sources, and on the experience of how New York, Greater London, Tokyo and Paris have grappled with the challenges of protecting population health and providing their populations with access to health care services. In some respects, there are some important lessons from comparative experience for PRD, notably the importance of covering the entire population for health care services and targeting special programs for those at highest risk for disease. In other respects, PRD's growth rate and sheer scale make it a unique megacity region that already faces new challenges and will require new solutions.

AB - While the growth of urbanization, worldwide, has improved the lives of migrants from the hinterland, it also raises health risks related to population density, concentrated poverty and the transmission of infectious disease. Will megacity regions evolve into socially infected breeding grounds for the rapid transmission of disease, or can they become critical spatial entities for the protection and promotion of population health? We address this question for the Pearl River Delta Region (PRD) based on recent data from Chinese sources, and on the experience of how New York, Greater London, Tokyo and Paris have grappled with the challenges of protecting population health and providing their populations with access to health care services. In some respects, there are some important lessons from comparative experience for PRD, notably the importance of covering the entire population for health care services and targeting special programs for those at highest risk for disease. In other respects, PRD's growth rate and sheer scale make it a unique megacity region that already faces new challenges and will require new solutions.

UR - http://www.scopus.com/inward/record.url?scp=80053438437&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053438437&partnerID=8YFLogxK

U2 - 10.1186/1741-7015-9-110

DO - 10.1186/1741-7015-9-110

M3 - Comment/debate

C2 - 21968214

AN - SCOPUS:80053438437

VL - 9

JO - BMC Medicine

JF - BMC Medicine

SN - 1741-7015

M1 - 110

ER -